On the other side, some preclinical researches exhibited that the SGLT2 inhibitors have anti-proliferative effects on several malignancies 28, and the possibilities of lung cancer and non-melanoma skin cancer may be reduced by SGLT2 inhibition 27. The gene discussed is SLC5A2; the disease is non-melanoma skin carcinoma.